| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.13 | 0.02 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |